Stock Events

Arrowhead Pharmaceuticals (ARWR) Q3 2024 Earnings

8AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.92
-1.44
-0.95
-0.47

Details

Expected EPS
-0.528927
Actual EPS
-1.38
Surprise EPS
-0.85
Surprise Percent
+160.91%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.38 per share for Q3 2024.

0 Comments

Share your thoughts